Abstract:Objective To study the correlation between the expression of CD44 splicing variant 5 (CD44v5) and the lymph node metastasis of gastric cancer. Methods One hundred and two formalin-fixed, paraffin-embodied gastric samples were examined for immunohistochemical staining with specific anti-CD44v5 monoclonal antibody by streptavidin-peroxidase method. The samples included 48 cases of gastric carcinoma, 8 gastric mucosa near benign gastric ulcer,13 chronic superficial gastritis. Results In benign diseases CD44v5 was only focally expressed in the mucosa of intestinal metaplasia of 8 cases of gastric ulcer and 13 cases of chronic superficial gastritis. In gastric carcinoma 60.4% cases showed a positive CD44v5 expression however the expression rate was higher in cases with lymph node metastasis(76.9%)than that without lymph node metastasis(40.9%,χ2=6.463,P0.05). No significant association was found between CD44v5 expression with gender of patients and the infiltrating depth of gastric carcinoma. Conclusion The expression of CD44v5 may be involved in lymph node metastasis in gastric carcinoma.

Expression of CD44v5 in Gastric Cancer:Relationships with Lymph Node Metastasis